Allspring Global Investments’s Akoya BioSciences AKYA Stock Holding History

Allspring Global Investments’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,991	Closed	-$23.2K	–	2227
2023 Q3	$23.2K	Sell	4,991 -1,001	-17%	-$5.75K	﹤0.01%	2476
2023 Q2	$44.3K	Sell	5,992 -112,954	-95%	-$754K	﹤0.01%	2318
2023 Q1	$973K	Sell	118,946 -69,802	-37%	-$729K	﹤0.01%	1420
2022 Q4	$1.81M	Buy	188,748 +12	+0%	+$148	﹤0.01%	1279
2022 Q3	$2.22M	Sell	188,736 -42,484	-18%	-$560K	﹤0.01%	1205
2022 Q2	$2.97M	Sell	231,220 -250,233	-52%	-$2.59M	0.01%	1125
2022 Q1	$5.29M	Sell	481,453 -7,622	-2%	-$88.4K	0.01%	1123
2021 Q4	$7.49M	Buy	+489,075	New	+$6.4M	0.01%	1024

Other funds holding AKYA

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments's AKYA Position: Q4 2023 in Review

Allspring Global Investments sold out of Akoya BioSciences (AKYA) in Q4 2023, closing a stake of 4,991 shares — an estimated $23.2K sold.

Allspring Global Investments first reported a position in AKYA in Q4 2021 and held it in 8 quarters. The position peaked at $7.49M in Q4 2021. 65 funds tracked by Wall St. Rank hold AKYA as of Q4 2023.

Allspring Global Investments reported no remaining Akoya BioSciences position as of Q4 2023 after selling out during the quarter.
Allspring Global Investments sold 4,991 Akoya BioSciences shares in Q4 2023, an estimated $23.2K.
Allspring Global Investments first reported a position in Akoya BioSciences in Q4 2021 and held it in 8 quarters.
Allspring Global Investments's Akoya BioSciences position peaked at $7.49M in Q4 2021.
65 funds tracked by Wall St. Rank held Akoya BioSciences as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.